Moreover, our previous work in a systemic sclerosis (SSc) model provides additional context, where HU-308’s effects were markedly diminished in the absence of CB2, underscoring its receptor-specific activity (Tian et al., 2024). Here, CNR2 is linked to systemic sclerosis.